Stroke and bleeding in atrial fibrillation with chronic kidney disease.

By J. Olesen, G. Lip, A. Kamper, Kristine Hommel, L. Køber, D. Lane, J. Lindhardsen, G. Gislason, C. Torp-Pedersen. New England Journal of Medicine, 2012

909 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Hematology, Nephrology

View Paper: https://www.semanticscholar.org/paper/baa4cc68c2949c60d53ae09c2b1d344ae3b8bd44

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Gregory Y. H. Lip
2. Cynthia Rudin

Citations in the corpus

• 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016, neutral): “4 Oral anticoagulation in atrial fibrillation patients with chronic kidney disease CKD is associated with stroke and bleeding in large data sets.(410,411) Anticoagulation can be safely used in AF patients with moderate or moderate-to-severe CKD [glomerular filtration rate (GFR) ≥15 mL/min]: the SPAF”
• Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report (2012, background): “There is also an increased risk of bleeding in individuals with AF and CKD, compared with those without CKD.(50) Conversely, AF is associated with an increased risk of CKD (RR, 1.”